Is neoadjuvant therapy redefining the surgeon’s role in melanoma?

Roger Olofsson Bagge

Open source

DOI
10.1080/14796694.2026.2737581
Published
2026-09-24
Container
Future Oncology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2737581,
  title = {Is neoadjuvant therapy redefining the surgeon’s role in melanoma?},
  author = {Roger Olofsson Bagge},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2737581},
  url = {https://doi.org/10.1080/14796694.2026.2737581}
}

RIS

TY  - JOUR
TI  - Is neoadjuvant therapy redefining the surgeon’s role in melanoma?
AU  - Roger Olofsson Bagge
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2737581
UR  - https://doi.org/10.1080/14796694.2026.2737581
ER  - 

APA

Bagge, R. O. (2026). Is neoadjuvant therapy redefining the surgeon’s role in melanoma?. Future Oncology. https://doi.org/10.1080/14796694.2026.2737581

Source records